These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29218888)

  • 1. Identifying natural health product and dietary supplement information within adverse event reporting systems.
    Sharma V; Sarkar IN
    Pac Symp Biocomput; 2018; 23():268-279. PubMed ID: 29218888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
    Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
    J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.
    Raschi E; Girardi A; Poluzzi E; Forcesi E; Menniti-Ippolito F; Mazzanti G; De Ponti F
    Drug Saf; 2018 Aug; 41(8):745-752. PubMed ID: 29582393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary Supplement Adverse Event Report Data From the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013.
    Timbo BB; Chirtel SJ; Ihrie J; Oladipo T; Velez-Suarez L; Brewer V; Mozersky R
    Ann Pharmacother; 2018 May; 52(5):431-438. PubMed ID: 29171279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serious Adverse Events Reported with Dietary Supplement Use in the United States: A 2.5 Year Experience.
    Schmitz SM; Lopez HL; Mackay D; Nguyen H; Miller PE
    J Diet Suppl; 2020; 17(2):227-248. PubMed ID: 30513022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
    Fahim SM; Mishuk AU; Cheng N; Hansen R; Calderón AI; Qian J
    Expert Opin Drug Saf; 2019 Feb; 18(2):145-152. PubMed ID: 30576263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FINDING POTENTIALLY UNSAFE NUTRITIONAL SUPPLEMENTS FROM USER REVIEWS WITH TOPIC MODELING.
    Sullivan R; Sarker A; O'Connor K; Goodin A; Karlsrud M; Gonzalez G
    Pac Symp Biocomput; 2016; 21():528-39. PubMed ID: 26776215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using natural language processing to characterize and predict homeopathic product-associated adverse events in consumer reviews: comparison to reports to FDA Adverse Event Reporting System (FAERS).
    Konkel K; Oner N; Ahmed A; Jones SC; Berner ES; Zengul FD
    J Am Med Inform Assoc; 2023 Dec; 31(1):70-78. PubMed ID: 37847653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Language Processing and Its Implications for the Future of Medication Safety: A Narrative Review of Recent Advances and Challenges.
    Wong A; Plasek JM; Montecalvo SP; Zhou L
    Pharmacotherapy; 2018 Aug; 38(8):822-841. PubMed ID: 29884988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The state of dietary supplement adverse event reporting in the United States.
    Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutravigilance: principles and practices to enhance adverse event reporting in the dietary supplement and natural products industry.
    Schmitz SM; Lopez HL; MacKay D
    Int J Food Sci Nutr; 2014 Mar; 65(2):129-34. PubMed ID: 24112316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary supplement adverse event reports: review and analysis.
    Talati AR; Gurnani AK
    Food Drug Law J; 2009; 64(3):503-13. PubMed ID: 19999641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Building a knowledge base of severe adverse drug events based on AERS reporting data using semantic web technologies.
    Jiang G; Wang L; Liu H; Solbrig HR; Chute CG
    Stud Health Technol Inform; 2013; 192():496-500. PubMed ID: 23920604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary supplements: a call to action.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):330-2. PubMed ID: 21133740
    [No Abstract]   [Full Text] [Related]  

  • 15. United States pharmacopeia safety evaluation of spirulina.
    Marles RJ; Barrett ML; Barnes J; Chavez ML; Gardiner P; Ko R; Mahady GB; Low Dog T; Sarma ND; Giancaspro GI; Sharaf M; Griffiths J
    Crit Rev Food Sci Nutr; 2011 Aug; 51(7):593-604. PubMed ID: 21793723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardisation of the FAERS database: a systematic approach to manually recoding drug name variants.
    Wong CK; Ho SS; Saini B; Hibbs DE; Fois RA
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):731-7. PubMed ID: 26017154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The state of adverse event reporting and signal generation of dietary supplements in Korea.
    Park KS; Kwon O
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):74-7. PubMed ID: 20074608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraction of adverse drug effects from clinical records.
    Aramaki E; Miura Y; Tonoike M; Ohkuma T; Masuichi H; Waki K; Ohe K
    Stud Health Technol Inform; 2010; 160(Pt 1):739-43. PubMed ID: 20841784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' understanding of the regulation of dietary supplements.
    Ashar BH; Rice TN; Sisson SD
    Arch Intern Med; 2007 May; 167(9):966-9. PubMed ID: 17502539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.